Skip to main content
Log in

Stagnation in OTC drug growth

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Government healthcare reforms and the increasing desire of patients to treat themselves have led world experts to predict explosive growth of over-the-counter (OTC) medicines. According to Eric Décosterd from Zyma SA, in Nyon, Switzerland, ‘some of these experts were even predicting that around the year 2000 the self-medication market would be almost as big as the prescription business’. It now appears that such predictions may be way off the mark. Delegates at the conference,Continuing Pharmaceutical Growth in the Face of Ongoing US and European Healthcare Reforms’, organised by IIR Ltd, heard possible explanations for the turn of fortune for OTC pharmaceuticals. The conference was held in London, UK, in March.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Short, R. Stagnation in OTC drug growth. Inpharma Wkly. 933, 4 (1994). https://doi.org/10.2165/00128413-199409330-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199409330-00006

Keywords

Navigation